Johnson & Johnson partners with BARDA to fund $1 billion in COVID-19 vaccine research
Published
Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to fund over $1 billion in COVID-19 vaccine and antiviral treatment research and development, the company said on Monday. The partnership is an expansion of an existing agreement between BARDA and […]
Full Article